Results 101 to 110 of about 14,076 (220)

Amiloride inhibits uPAR constitutive uptake in a dose-dependent manner.

open access: yes, 2013
Panel A. Biotinylation experiments in HEK293-uPAR cells incubated in the absence or presence of amiloride. Lane 1: background, Lane 2: constitutively internalized uPAR, Lane 3: inhibition by amiloride.
Francesco Blasi (61418)   +4 more
core   +1 more source

Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells

open access: yesBMC Cancer, 2010
Background uPAR and MMP-9, which play critical roles in tumor cell invasion, migration and angiogenesis, have been shown to be associated with lipid rafts.
Estes Norman   +5 more
doaj   +1 more source

The uPA/uPAR system in astrocytic wound healing

open access: yesNeural Regeneration Research, 2022
The repair of injured tissue is a highly complex process that involves cell proliferation, differentiation, and migration. Cell migration requires the dismantling of intercellular contacts in the injured zone and their subsequent reconstitution in the wounded area. Urokinase-type plasminogen activator (uPA) is a serine proteinase found in multiple cell
openaire   +3 more sources

Spontaneous ‘uPAR-rich’ cell selection in the monolayer by a uPAR-plasmin-TGFβ1 positive feedback loop.

open access: yes, 2018
All cells in the model (A) express the same level of uPAR (the uPAR concentration in the cells is indicated by the red color) at initialization of a simulation.
Joao Carvalho (5487974)   +6 more
core   +1 more source

Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer

open access: yesBMC Cancer, 2017
Background Tumor-specific biomarkers are a prerequisite for the development of targeted imaging and therapy in oral squamous cell carcinoma (OSCC). urokinase-type Plasminogen Activator Receptor (uPAR), Tissue Factor (TF) and Epidermal Growth Factor ...
Anders Christensen   +11 more
doaj   +1 more source

Urokinase Receptor and Resistance to Targeted Anticancer Agents

open access: yesFrontiers in Pharmacology, 2015
The urokinase receptor/uPAR is a GPI-anchored membrane protein, which regulates protease activity at the cell surface and, in collaboration with a system of co-receptors, triggers cell-signaling and regulates gene expression within the cell.
Steven L. Gonias, Jingjing eHu
doaj   +1 more source

Ultrastructural visualization of uPAR endocytic vesicles.

open access: yes, 2013
HEK293-uPAR cells were incubated with anti-uPAR monoclonal antibody R3 (that recognizes the D1 extracellular domain) at 4°C for 20 minutes, washed and then probed with protein A gold 10 nm in the absence and in the presence of 200 nM RAP. After extensive
Francesco Blasi (61418)   +4 more
core   +1 more source

Cytoplasmic and membrane staining of uPAR.

open access: yes, 2014
Representative photomicrographs of tissue microarray sections stained for uPAR, showing typical A) membrane and B) cytoplasmic localized staining of the tumour cells. Scalebar = 50 µm.
Lars Uhlin-Hansen (350451)   +5 more
core   +1 more source

uPAR is not required for skeletal muscle regeneration

open access: yesThe FASEB Journal, 2006
Muscle regeneration has been shown to be severely impaired in urokinase‐type plasminogen activator deficient (uPA‐/‐) mice, and the impaired regeneration was associated with a lack of macrophage accumulation following muscle injury. Many studies have demonstrated that the receptor for uPA (uPAR) plays an important role in inflammatory cell migration ...
Scott C Bryer, Timothy J Koh
openaire   +1 more source

Abstract 831: uPAR Expression is Up-regulated in Cervical Cancer

open access: yes, 2010
Hypoxia occurs during development of cervical cancer and is considered to correlate with its invasion. Hypoxia induces cancer cells to have more invasive property through the urokinase plasminogen activator receptor (uPAR) expression.
Hirotaka Nishi   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy